Study the effect of Nagaradi Kwath eye drops in Kaphaj Abhishyanda that is Acute Mucopurulant Conjunctivitis.
Phase 1
- Conditions
- Health Condition 1: H100- Mucopurulent conjunctivitis
- Registration Number
- CTRI/2019/10/021693
- Lead Sponsor
- A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients having signs and symptoms of Kaphaj Abhishynada.
Exclusion Criteria
Patient other than Kaphaj abhishyanda.
patients having Kaphaj Abhishyanda with any other major systemic illness.
If any type of corneal involvement.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To evaluate the effect of Nagaradi Kwath Aschotan in Kaphaj Abhishyanda patients.Timepoint: 3rd, 5th, 7th, 10th days for trial medication, observations and 15th day for observation only. <br/ ><br>Total study duration is of 2 years. <br/ ><br>
- Secondary Outcome Measures
Name Time Method To evaluate the effect of Nagaradi kwath Aschotan to prevent deterioration in patients of kaphaj abhishyanda. <br/ ><br>To sudy and compare the sign and symptoms of Kaphaj Abhishyanda with modern science disease. <br/ ><br>To find out irritation and results of the trial drug in conjunctiva of Rabbit Model. <br/ ><br>To find out cost effectiveness of the treatment. <br/ ><br>To see the Adverse effects of the drug if any. <br/ ><br>Timepoint: 3rd, 5th, 7th, 10th days for trial medication, observations and 15th day for observation only. <br/ ><br>Total study duration is of 2 years. <br/ ><br>